<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28584117</article-id>
<article-id pub-id-type="pmc">5488951</article-id>
<article-id pub-id-type="publisher-id">201704547</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1704547114</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Neuroscience</subject>
</subj-group>
</subj-group>
<series-title>From the Cover</series-title>
</article-categories>
<title-group>
<article-title>Histamine modulation of the basal ganglia circuitry in the development of pathological grooming</article-title>
<alt-title alt-title-type="short">Histamine modulation of the basal ganglia</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rapanelli</surname>
<given-names>Maximiliano</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Frick</surname>
<given-names>Luciana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-6315-9594</contrib-id>
<name>
<surname>Bito</surname>
<given-names>Haruhiko</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-2117-9321</contrib-id>
<name>
<surname>Pittenger</surname>
<given-names>Christopher</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>4</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Department of Psychiatry, <institution>Yale University hool of Medicine</institution>, New Haven, <addr-line>CT</addr-line> 06510;</aff>
<aff id="aff2"><sup>b</sup>Department of Neurochemistry, Graduate School of Medicine, <institution>University of Tokyo</institution>, Tokyo 113-0033, <country>Japan</country>;</aff>
<aff id="aff3"><sup>c</sup>Department of Psychology, Child Study Center, and Interdepartmental Neuroscience Program, <institution>Yale University</institution>, New Haven, <addr-line>CT</addr-line> 06519</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>4</sup>To whom correspondence should be addressed. Email: <email>christopher.pittenger@yale.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Solomon H. Snyder, The Johns Hopkins University School of Medicine, Baltimore, MD, and approved May 11, 2017 (received for review March 19, 2017)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: M.R., L.F., and C.P. designed research; M.R., L.F., and C.P. performed research; H.B. contributed new reagents/analytic tools; M.R., L.F., and C.P. analyzed data; and M.R., L.F., H.B., and C.P. wrote the paper.</p>
</fn>
<fn fn-type="equal" id="fn1">
<p><sup>1</sup>M.R. and L.F. contributed equally to this work.</p>
</fn>
<fn fn-type="present-address" id="fn2">
<p><sup>2</sup>Present address: Department of Physiology &amp; Biophysics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo–State University of New York, Buffalo, NY 14214.</p>
</fn>
<fn fn-type="present-address" id="fn3">
<p><sup>3</sup>Present address: Hunter James Kelly Research Institute, Jacobs School of Medicine &amp; Biomedical Sciences, New York State Center of Excellence, University at Buffalo–State University of New York, Buffalo, NY 14203.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>20</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>5</day>
<month>6</month>
<year>2017</year>
</pub-date>
<volume>114</volume>
<issue>25</issue>
<fpage>6599</fpage>
<lpage>6604</lpage>
<permissions></permissions>
<self-uri xlink:href="pnas.201704547.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Dysregulation of brain histamine (HA) is a rare cause of Tourette syndrome and related conditions, but the associated pathophysiological mechanisms remain obscure. We show that repetitive behavioral pathology in mice derives from deficiency of neurotransmitter HA (rather than HA from other sources), acting in the dorsal striatum. These data provide a functional dissection of acute HA modulation in the brain and elucidate the anatomical correlates of pathological dysregulation when neuronal HA is disrupted.</p>
</abstract>
<abstract>
<p>Aberrant histaminergic function has been proposed as a cause of tic disorders. A rare mutation in the enzyme that produces histamine (HA), histidine decarboxylase (HDC), has been identified in patients with Tourette syndrome (TS). <italic>Hdc</italic> knockout mice exhibit repetitive behavioral pathology and neurochemical characteristics of TS, establishing them as a plausible model of tic pathophysiology. Where, when, and how HA deficiency produces these effects has remained unclear: whether the contribution of HA deficiency to pathogenesis is acute or developmental, and where in the brain the relevant consequences of HA deficiency occur. Here, we address these key pathophysiological questions, using anatomically and cellularly targeted manipulations in mice. We report that specific ablation or chemogenetic silencing of histaminergic neurons in the tuberomammillary nucleus (TMN) of the hypothalamus leads to markedly elevated grooming, a form of repetitive behavioral pathology, and to elevated markers of neuronal activity in both dorsal striatum and medial prefrontal cortex. Infusion of HA directly into the striatum reverses this behavioral pathology, confirming that acute HA deficiency mediates the effect. Bidirectional chemogenetic regulation reveals that dorsal striatum neurons activated after TMN silencing are both sufficient to produce repetitive behavioral pathology and necessary for the full expression of the effect. Chemogenetic activation of TMN-regulated medial prefrontal cortex neurons, in contrast, increases locomotion and not grooming. These data confirm the centrality of striatal regulation by neurotransmitter HA in the adult in the production of pathological grooming.</p>
</abstract>
<kwd-group>
<kwd>histamine</kwd>
<kwd>basal ganglia</kwd>
<kwd>grooming</kwd>
<kwd>striatum</kwd>
<kwd>Tourette syndrome</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">HHS | NIH | National Institute of Mental Health (NIMH)<named-content content-type="funder-id">100000025</named-content></funding-source>
<award-id rid="sp1">R01MH091861</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)<named-content content-type="funder-id">100000065</named-content></funding-source>
<award-id rid="sp2">R01NS101104</award-id>
</award-group>
<award-group id="gs3">
<funding-source id="sp3">Japan Society for the Promotion of Science (JSPS)<named-content content-type="funder-id">501100001691</named-content></funding-source>
<award-id rid="sp3">15H02358</award-id>
</award-group>
<award-group id="gs4">
<funding-source id="sp4">Japan Agency for Medical Research and Development</funding-source>
<award-id rid="sp4">Brain/MINDS program</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="6"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>